Cargando...

Personalized one-two punches for lung cancer

Discovery of individualized therapies to address resistance to tyrosine kinase inhibitors (TKIs) has been hampered by the inability to test drug combinations on patient samples before and after TKI resistance. A recent study published in Science by Crystal et al. describes a methodology for pharmaco...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cell Res
Autores principales: Scarborough, Hannah A, Bunn, Paul A, DeGregori, James
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349242/
https://ncbi.nlm.nih.gov/pubmed/25547118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2014.168
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!